Filing Details

Accession Number:
0001209191-12-053768
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-19 16:15:29
Reporting Period:
2012-03-19
Filing Date:
2012-11-19
Accepted Time:
2012-11-19 16:15:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
742112 Invacare Corp IVC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 952680965
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453022 Anthony Laplaca One Invacare Way
Elyria OH 44035
Sr. Vp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2012-03-19 4 $17.69 15,364 No 4 S Direct
Common Shares Disposition 2012-11-15 1,115 $13.02 14,249 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 F Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Employee Stock Option (Right to Buy) $0.00 73,200 73,200 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
73,200 73,200 Direct
Footnotes
  1. This transaction, in which shares were sold by the reporting person's financial advisor to cover the payment of brokerage fees due on the reporting person's account, is being reported late due to an inadvertant administrative oversight.
  2. The surrender of these shares is for tax withholding purposes in conjunction with the vesting of restricted shares held by the reporting person.
  3. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
  4. The reporting person holds previously reported options to buy 73,200 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between October 27, 2008 and August 14, 2012, at exercise prices between $13.37 and $25.24 per share, will expire between October 27, 2018 and August 14, 2022 and became or will become exercisable between September 30, 2009 and September 30, 2016.